Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
MicroRNA-668 represses MTP18 to preserve mitochondrial dynamics in ischemic acute kidney injury
Qingqing Wei, … , Changlin Mei, Zheng Dong
Qingqing Wei, … , Changlin Mei, Zheng Dong
Published December 3, 2018; First published October 16, 2018
Citation Information: J Clin Invest. 2018;128(12):5448-5464. https://doi.org/10.1172/JCI121859.
View: Text | PDF
Categories: Research Article Nephrology

MicroRNA-668 represses MTP18 to preserve mitochondrial dynamics in ischemic acute kidney injury

  • Text
  • PDF
Abstract

The pathogenesis of ischemic diseases remains unclear. Here we demonstrate the induction of microRNA-668 (miR-668) in ischemic acute kidney injury (AKI) in human patients, mice, and renal tubular cells. The induction was HIF-1 dependent, as HIF-1 deficiency in cells and kidney proximal tubules attenuated miR-668 expression. We further identified a functional HIF-1 binding site in the miR-668 gene promoter. Anti–miR-668 increased apoptosis in renal tubular cells and enhanced ischemic AKI in mice, whereas miR-668 mimic was protective. Mechanistically, anti–miR-668 induced mitochondrial fragmentation, whereas miR-668 blocked mitochondrial fragmentation during hypoxia. We analyzed miR-668 target genes through immunoprecipitation of microRNA-induced silencing complexes followed by RNA deep sequencing and identified 124 protein-coding genes as likely targets of miR-668. Among these genes, only mitochondrial protein 18 kDa (MTP18) has been implicated in mitochondrial dynamics. In renal cells and mouse kidneys, miR-668 mimic suppressed MTP18, whereas anti–miR-668 increased MTP18 expression. Luciferase microRNA target reporter assay further verified MTP18 as a direct target of miR-668. In renal tubular cells, knockdown of MTP18 suppressed mitochondrial fragmentation and apoptosis. Together, the results suggest that miR-668 is induced via HIF-1 in ischemic AKI and that, upon induction, miR-668 represses MTP18 to preserve mitochondrial dynamics for renal tubular cell survival and kidney protection.

Authors

Qingqing Wei, Haipeng Sun, Shuwei Song, Yong Liu, Pengyuan Liu, Man Jiang Livingston, Jianwen Wang, Mingyu Liang, Qing-Sheng Mi, Yuqing Huo, Norris Stanley Nahman, Changlin Mei, Zheng Dong

×

Figure 5

miR-668 mimic protects kidneys from ischemic AKI.

Options: View larger image (or click on image) Download as PowerPoint
miR-668 mimic protects kidneys from ischemic AKI.
(A) Schematic diagram ...
(A) Schematic diagram depicting the animal treatment procedure. miR-668 or negative control (NC) RNA oligonucleotides were delivered to C57BL/6J male mice through tail vein injection 1 day before ischemic surgery. The mice were subjected to 30 minutes of bilateral renal ischemia with 48 hours of reperfusion (I30/48h), or sham operation. (B) qPCR of miR-668 to verify successful RNA oligonucleotide delivery to mouse kidneys (n = 3; *P = 0.023, 2-tailed Student’s t test). (C) BUN measurement showing the protective effect of miR-668 (n = 3 for sham group negative control, n = 4 for sham group with miR-668, n = 6 for I30/48h negative control, n = 7 for I30/48h with miR-668; *P = 0.045 for I30/48h, 2-tailed Student’s t test). (D) Serum creatinine levels showing the protective effect of miR-668 (n = 3 for sham group negative control, n = 4 for sham group with miR-668, n = 6 for I30/48h with negative control, n = 7 for I30/48h with miR-668; *P = 0.021, 2-tailed Student’s t test). (E) Representative images of renal histology by H&E staining. Bottom panels are enlarged images of the boxed areas in the top panels. Scale bars: 0.2 mm. (F) Representative images of TUNEL staining. Scale bar: 0.2 mm. (G) Counting of TUNEL-positive cells to show the antiapoptotic effect of miR-668 in ischemic AKI (n = 3; *P = 0.0446, 2-tailed Student’s t test). (H) Immunoblots showing the inhibition of caspase-3 cleavage in ischemic AKI kidney with miR-668 overexpression. NC, negative control; 668, miR-668 mimics. Cyclophilin B was used as loading control.
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts